<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:59:24Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4693440" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4693440</identifier><datestamp>2015-12-30</datestamp><setSpec>molbrain</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
      <journal-title-group>
        <journal-title>Molecular Brain</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-6606</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4693440</article-id>
      <article-id pub-id-type="pmcid">PMC4693440</article-id>
      <article-id pub-id-type="pmc-uid">4693440</article-id>
      <article-id pub-id-type="pmid">26715324</article-id>
      <article-id pub-id-type="publisher-id">180</article-id>
      <article-id pub-id-type="doi">10.1186/s13041-015-0180-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A mutation in the low voltage-gated calcium channel <italic>CACNA1G</italic> alters the physiological properties of the channel, causing spinocerebellar ataxia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Morino</surname>
            <given-names>Hiroyuki</given-names>
          </name>
          <address>
            <phone>+81-82-257-5849</phone>
            <email>morino@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsuda</surname>
            <given-names>Yukiko</given-names>
          </name>
          <address>
            <email>yoshimot@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Muguruma</surname>
            <given-names>Keiko</given-names>
          </name>
          <address>
            <email>muguruma@cdb.riken.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miyamoto</surname>
            <given-names>Ryosuke</given-names>
          </name>
          <address>
            <email>rmiyamoto@clin.med.tokushima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohsawa</surname>
            <given-names>Ryosuke</given-names>
          </name>
          <address>
            <email>rohsawa@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ohtake</surname>
            <given-names>Toshiyuki</given-names>
          </name>
          <address>
            <email>toshiyuki_ohtake@tokyo-hmt.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Otobe</surname>
            <given-names>Reiko</given-names>
          </name>
          <address>
            <email>reiko0261@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watanabe</surname>
            <given-names>Masahiko</given-names>
          </name>
          <address>
            <email>watamasa@med.hokudai.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maruyama</surname>
            <given-names>Hirofumi</given-names>
          </name>
          <address>
            <email>hmaru@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hashimoto</surname>
            <given-names>Kouichi</given-names>
          </name>
          <address>
            <email>hashik@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kawakami</surname>
            <given-names>Hideshi</given-names>
          </name>
          <address>
            <phone>+81-82-257-5846</phone>
            <email>hkawakam@hiroshima-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553 Japan </aff>
        <aff id="Aff2"><label/>Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe, Japan </aff>
        <aff id="Aff3"><label/>Department of Neurology, Tokyo Metropolitan Health and Medical Treatment Corporation Ebara Hospital, Tokyo, Japan </aff>
        <aff id="Aff4"><label/>Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan </aff>
        <aff id="Aff5"><label/>Department of Anatomy, Hokkaido University Graduate School of Medicine, Sapporo, Japan </aff>
        <aff id="Aff6"><label/>Department of Clinical Neuroscience &amp; Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan </aff>
        <aff id="Aff7"><label/>Department of Neurophysiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>29</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>89</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Morino et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Spinocerebellar ataxia (SCA) is a genetically heterogeneous disease. To date, 36 dominantly inherited loci have been reported, and 31 causative genes have been identified.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>In this study, we analyzed a Japanese family with autosomal dominant SCA using linkage analysis and exome sequencing, and identified <italic>CACNA1G</italic>, which encodes the calcium channel Ca<sub>V</sub>3.1, as a new causative gene. The same mutation was also found in another family with SCA. Although most patients exhibited the pure form of cerebellar ataxia, two patients showed prominent resting tremor in addition to ataxia. Ca<sub>V</sub>3.1 is classified as a low-threshold voltage-dependent calcium channel (T-type) and is expressed abundantly in the central nervous system, including the cerebellum. The mutation p.Arg1715His, identified in this study, was found to be located at S4 of repeat IV, the voltage sensor of the Ca<sub>V</sub>3.1. Electrophysiological analyses revealed that the membrane potential dependency of the mutant Ca<sub>V</sub>3.1 transfected into HEK293T cells shifted toward a positive potential. We established induced pluripotent stem cells (iPSCs) from fibroblasts of the patient, and to our knowledge, this is the first report of successful differentiation from the patient-derived iPSCs into Purkinje cells. There was no significant difference in the differentiation status between control- and patient-derived iPSCs.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>To date, several channel genes have been reported as causative genes for SCA. Our findings provide important insights into the pathogenesis of SCA as a channelopathy.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13041-015-0180-4) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Spinocerebellar ataxia</kwd>
        <kwd>
          <italic>CACNA1G</italic>
        </kwd>
        <kwd>T-type calcium channel</kwd>
        <kwd>Ca<sub>V</sub>3.1</kwd>
        <kwd>Induced pluripotent stem cell</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>15K15083</award-id>
          <principal-award-recipient>
            <name>
              <surname>Morino</surname>
              <given-names>Hiroyuki</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Ministry of Education, Culture, Sports, Science and Technology of Japan </institution>
          </funding-source>
          <award-id>26242085</award-id>
          <principal-award-recipient>
            <name>
              <surname>Kawakami</surname>
              <given-names>Hideshi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>23111008</award-id>
          <principal-award-recipient>
            <name>
              <surname>Kawakami</surname>
              <given-names>Hideshi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>AMED</institution>
          </funding-source>
          <award-id>the Core Program for Disease Modeling Using iPS Cells 15bm0609002h0104</award-id>
          <principal-award-recipient>
            <name>
              <surname>Muguruma</surname>
              <given-names>Keiko</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Spinocerebellar ataxia (SCA) is characterized by cerebellar ataxia, dysarthria, oculomotor disorder, extrapyramidal sign, motor neuron sign, epilepsy, cognitive impairment, and many other symptoms [<xref ref-type="bibr" rid="CR1">1</xref>]. To date, 36 loci have been shown to be involved in autosomal dominant SCA, and the causative genes and mutations have been identified for 31 types of SCAs [<xref ref-type="bibr" rid="CR2">2</xref>]. The majority of SCAs account for repeat expansion, including a coding CAG repeat (SCA1â3, 6, 7, 17, and dentatorubral-pallidoluysian atrophy) causing misfolding of the encoded protein due to the expanded polyglutamine tracts; groups of noncoding CAG, CTG, ATTCT, and GGCCTG repeats (SCA8, 10, 12, and 36); and large TGGAA repeat insertions (SCA31) that induce RNA-mediated gain-of-function mechanisms. The remaining known SCA types are caused by single nucleotide variants or indels (SCA5, 11, 13â15, 18â21, 23, 26â28, 34, 35, 38, 40, and 41) in genes that encode various functional proteins [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p><italic>CACNA1A</italic> (MIM 601011) was first reported as a causative gene of SCA6 (MIM 183086) among the genes encoding channels [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. In recent years, potassium channel mutations have been described in SCA13 (MIM 605259) and SCA19/22 (MIM 607346) [<xref ref-type="bibr" rid="CR5">5</xref>â<xref ref-type="bibr" rid="CR7">7</xref>]. Episodic ataxia (EA) is one of the diseases associated with SCA, and some types of EA are caused by mutations in calcium channel. <italic>CACNA1A</italic> and <italic>CACNB4</italic> mutations lead to EA2 (MIM 108500) and EA5 (MIM 613855), respectively [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Thus the ion channel dysfunction plays a key role in the pathogenesis of ataxia and related diseases.</p>
      <p>We have been engaged in clinicogenetic research using the samples from more than 2,000 patients with SCA. From a thorough examination of the disease types and the geographical distributions of the 2,121 patients, causative genes for 26.6Â % of the dominant-inherited cases (205 out of 721) are still unknown [<xref ref-type="bibr" rid="CR10">10</xref>]. Therefore, in order to identify novel causative genes, we applied exome sequencing to the families with dominantly inherited SCA.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Patients</title>
        <p>We enrolled two Japanese families with segregating dominant traits for cerebellar ataxia. There are 10 affected individuals in the family 1 and five in the family 2. Blood samples were obtained from eight affected individualsÂ and three unaffected individuals in family 1, and five affected individuals and two unaffected individuals in family 2 (Fig.Â <xref rid="Fig1" ref-type="fig">1a</xref>). All patients were diagnosed with SCA by neurologists. Prior to this study, we confirmed that all affected individuals had no pathogenic mutations causing SCA1â3, 6, 8, and dentatorubral-pallidoluysian atrophy. The study was approved by the Human Subjects Committees of Hiroshima University; all subjects provided written informed consent.<fig id="Fig1"><label>Fig. 1</label><caption><p>Identification of a mutation in <italic>CACNA1G</italic> causing SCA. <bold>a</bold> Pedigree charts of families 1 and 2. Arrows indicate the probands. Filled and open symbols represent affected and unaffected individuals, respectively. Genotypes of the variant c.5144Gâ&gt;âA are shown under the number of samples. Asterisks indicate the patients used for exome sequencing. <bold>b</bold>, <bold>c</bold> Results of linkage analysis. Arrows indicate the positions of <italic>CACNA1G</italic>. <bold>d</bold> Sanger sequencing to confirm the <italic>CACNA1G</italic> variant. The reference nucleotide G is overlapped with variant nucleotide A in the mutant sample. <bold>e</bold> Structure of Ca<sub>V</sub>3.1 encoded by <italic>CACNA1G</italic>. The star indicates the position of the identified mutation. The mutation was located in the segment 4 (S4) of the fourth repeat. <bold>f</bold> Conservation at the location of the mutation. The nucleotide and amino acid sequences are completely conserved among vertebrates. <bold>g</bold> Haplotype analysis. From the result of SNP genotyping, the haplotypes of both families around the <italic>CACNA1G</italic> gene coincided for 360Â kb</p></caption><graphic xlink:href="13041_2015_180_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Linkage analysis</title>
        <p>The samples used for linkage analysis were 1-III-2, 1-III-4, 1-III-6, 1-III-8, 1-III-11, 1-III-13, 1-IV-2, 1-IV-3, and 1-IV-4. Because it was possible that 1-IV-3 and 1-IV-4 did not reach the appropriate age at onset, the two samples were treated as unknown in the pedigree file of linkage analysis. Genomic DNA (gDNA) was extracted from the peripheral lymphocytes of the participants according to standard protocols. We used a Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) for genotyping of single nucleotide polymorphisms (SNPs), and linkage analysis was performed by Allegro software, estimating the dominant inheritance [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Exome Sequencing</title>
        <p>Exome sequencing was carried out using three samples from 1-III-6, 1-III-11, and 1-III-13, as previously described [<xref ref-type="bibr" rid="CR12">12</xref>]. For family 2, exome sequencing was also performed with the sample from 2-III-1. gDNA libraries were prepared using a SeqCap EZ Human Exome Library v2.0 (Roche, Basel, Switzerland). Sequencing was performed with 100-bp paired-end reads on a HiSeq2000 sequencer (Illumina, San Diego, CA, USA). We used BWA (<ext-link ext-link-type="uri" xlink:href="http://bio-bwa.sourceforge.net/">http://bio-bwa.sourceforge.net/</ext-link>) [<xref ref-type="bibr" rid="CR13">13</xref>] for alignment and mapping, Samtools (<ext-link ext-link-type="uri" xlink:href="http://samtools.sourceforge.net/">http://samtools.sourceforge.net/</ext-link>) [<xref ref-type="bibr" rid="CR14">14</xref>] and Picard (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>) for SAM/BAM handling, GATK (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gatk/">http://www.broadinstitute.org/gatk/</ext-link>) [<xref ref-type="bibr" rid="CR15">15</xref>] and Samtools for variant calls, and Annovar (<ext-link ext-link-type="uri" xlink:href="http://annovar.openbioinformatics.org/">http://annovar.openbioinformatics.org/</ext-link>) [<xref ref-type="bibr" rid="CR16">16</xref>] for annotation. Functional predictions due to amino acid changes were estimated using PolyPhen-2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>) [<xref ref-type="bibr" rid="CR17">17</xref>], SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.bii.a-star.edu.sg/">http://sift.bii.a-star.edu.sg/</ext-link>) [<xref ref-type="bibr" rid="CR18">18</xref>], and Mutation Taster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/index.html">http://www.mutationtaster.org/index.html</ext-link>) [<xref ref-type="bibr" rid="CR19">19</xref>]. Control exome sequences were obtained from Japanese patients undergoing exome analysis for diseases other than SCA. All reported genomic coordinates were in GRCh37/hg19. The identified mutations were validated with a standard polymerase chain reaction (PCR)-based amplification followed by sequence analysis with an Applied Biosystems 3130 DNA sequencer (Thermo Fisher Scientific, Waltham, MA, USA).</p>
      </sec>
      <sec id="Sec6">
        <title>Expression vector</title>
        <p>Wild-type <italic>CACNA1G</italic> (short isoform; BC110995.1, NM_198382.2) in the pCMV-SPORT6 plasmid (pCMV-SPORT6-CACNA1G) was purchased from Dharmacon (Lafayette, CO, USA). The mutation c.5075Gâ&gt;âA corresponding to c.5144Gâ&gt;âA in the longest isoform (NM_018896.4) was introduced by site-directed mutagenesis using QuikChange Lightning (Agilent Technologies, Santa Clara, CA, USA) and verified by bidirectional sequencing. The IRES-EGFP sequence was amplified by PCR from the pIRES-EGFP plasmid and inserted at the termination codon of the cDNA sequence in pCMV-SPORT6-CACNA1G (pCMV-SPORT6-CACNA1G-IG) using an In-Fusion HD Cloning Kit (TaKaRa Bio, Shiga, Japan).</p>
      </sec>
      <sec id="Sec7">
        <title>Cell culture, transfection, and immunofluorescence</title>
        <p>The primary antibodies used in this study were anti-CACNA1G [<xref ref-type="bibr" rid="CR20">20</xref>], and anti-alpha 1 sodium potassium ATPase (Abcam, Cambridge, UK).</p>
        <p>HeLa and HEK293T cells were maintained in Dulbeccoâs modified Eagleâs medium (DMEM; Nakarai Tesque, Kyoto, Japan) supplemented with 10Â % fetal bovine serum and penicillin/streptomycin (PS) in a 37Â Â°C incubator with 5Â % CO<sub>2</sub>. For immunofluorescence analysis, cells were grown on chamber slides (SCS-008; Matsunami, Osaka, Japan) coated with poly-<sc>l</sc>-lysine (Sigma-Aldrich, St. Louis, MO, USA), and were transiently transfected with pCMV-SPORT6-CACNA1G using Lipofectamine LTX (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturerâs instructions. After 48â72Â h, the cells were fixed in 4Â % paraformaldehyde, washed with phosphate-buffered saline (PBS), blocked, and permeabilized with 0.2Â % Tween20. Cells were incubated overnight at 4Â Â°C with anti-CACNA1G and anti-alpha 1 sodium potassium ATPase antibodies and then treated with secondary antibodies. Images were obtained using confocal microscopy (LSM510; Carl Zeiss, Jena, Germany). The nuclei were visualized using DAPI.</p>
        <p>Cells for whole-cell patch clamping were grown in glass-bottom plates (Î¼-Dish 35Â mm low; ibidi, Martinsried, Germany) for 24Â h following transfection with SPORT6-CACNA1G-IG using Lipofectamine LTX.</p>
      </sec>
      <sec id="Sec8">
        <title>Electrophysiology</title>
        <p>Whole-cell recordings were made from GFP-expressing HEK293T cells using an upright microscope (BX51WI; Olympus, Tokyo, Japan) equipped with an IR-CCD camera system (IR-1000; DAGE-MTI, Michigan, IN, USA) at room temperature. The intracellular solution was composed of 110Â mM CsCl, 20Â mM TEA-Cl, 10Â mM NaCl, 5Â mM EGTA, 10Â mM HEPES, 4Â mMÂ Mg-ATP, and 0.4Â mM 2Na-GTP (pHÂ 7.3, adjusted with CsOH). The pipette access resistance was about 2â3 MÎ©. The composition of the extracellular solution was 10Â mM NaCl, 105Â mM TEA-Cl, 10Â mM 4-AP, 2.5Â mM KCl, 2Â mM CaCl<sub>2</sub>, 1Â mM MgSO<sub>4</sub>, 1.25Â mM NaH<sub>2</sub>PO<sub>4</sub>, 26Â mM NaHCO<sub>3</sub>, and 20Â mM glucose, bubbled with 95Â % O<sub>2</sub> and 5Â % CO<sub>2</sub>. Ionic currents were recorded with an EPC-10 (HEKA Elektronik, Lambrecht, Germany). The signals were filtered at 3Â kHz and digitized at 20Â kHz. On-line data acquisition and off-line data analysis were performed using PATCHMASTER software (HEKA Elektronik, Lambrecht, Germany). Relative conductance and steady-state inactivation plots were fitted by the following Boltzmann equations:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{ll}\frac{G}{G_{max}}\hfill &amp; =\frac{1}{1+ exp\left(\left({V}_{half}-{V}_m\right)/k\right)}\hfill \\ {}\frac{I}{I_{max}}\hfill &amp; =\frac{1}{1+ exp\left(\left({V}_m-{V}_{half}\right)/k\right)}\hfill \end{array} $$\end{document}</tex-math><mml:math xmlns:mml="https://jats.nlm.nih.gov/ns/archiving/1.0/" id="M2"><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mfrac><mml:mi>G</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi mathvariant="italic">max</mml:mi></mml:msub></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi mathvariant="italic">exp</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi mathvariant="italic">half</mml:mi></mml:msub><mml:mo>â</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo stretchy="true">/</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mfrac><mml:mi>I</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mi mathvariant="italic">max</mml:mi></mml:msub></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi mathvariant="italic">exp</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>â</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mi mathvariant="italic">half</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo stretchy="true">/</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="13041_2015_180_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      </sec>
      <sec id="Sec9">
        <title>Derivation of patient-specific fibroblasts and generation of induced pluripotent stem cells (iPSCs)</title>
        <p>Patient 2-III-1 harbored the <italic>CACNA1G</italic> mutation. Thus, a 3-mm punched skin biopsy was obtained from the upper arm. The skin sample was mechanically cut into small pieces and cultured in 100-mm cell culture dishes in DMEM containing 20Â % fetal bovine serum. Outgrowth of dermal fibroblasts appeared after 7â14 days, and cultures were split at 1:3 after reaching 80Â % confluence. Peripheral blood was obtained from a healthy donor after providing written informed consent in accordance with the institutional review board guidelines. Peripheral blood mononuclear cells (PBMCs) were purified by density gradient centrifugation with a BD Vacutainer CPT (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturerâs instructions.</p>
        <p>Human complementary DNAs for reprogramming factors were transduced into dermal fibroblasts and PBMCs with episomal vectors (pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL; Addgene, Cambridge, MA, USA) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. The generated iPSCs were maintained on a mitomycin C-inactivated SNL feeder cell layer in DMEM/F12 containing GlutaMaxI (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 20Â % KnockOut Serum Replacement (KSR; Thermo Fisher Scientific, Waltham, MA, USA), 5Â ng/ml recombinant human FGF basic (Wako, Osaka, Japan), 0.1Â mM Î²-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) and PS under 5Â % CO<sub>2</sub>.</p>
      </sec>
      <sec id="Sec10">
        <title>Purkinje cell differentiation from iPSCs</title>
        <p>The differentiation of Purkinje cells from iPSCs was performed as described previously [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec11">
      <title>Results</title>
      <sec id="Sec12">
        <title>Clinical manifestations</title>
        <p>The proband 1-III-13 has exhibited the pure form of cerebellar ataxia, and her age of at disease onset was 45Â years. The main symptoms were ataxic gait, dysarthria, and gaze-evoked horizontal nystagmus. Cognitive impairment, epilepsy, muscle atrophy, involuntary movement, and parkinsonism were not observed. The parents did not exhibit the same symptoms; however, symptoms were observed in her uncles. Her sister (1-III-11) also suffered from the same symptoms, with slightly increased severity. Other affected members in the family 1 showed similar clinical features, and the age at onset varied from 20 to 70Â years. In all patients, progression of the disease was relatively slow.</p>
        <p>For family 2, the age at onset ranged from 18 to 57Â years. The main symptoms and clinical course were similar to those in family 1, except that two patients 2-II-2 and 2-III-2 showed prominent resting tremors.</p>
        <p>In neuroimaging, brain magnetic resonance imaging (MRI) results of 2-III-1 demonstrated cerebellar atrophy, typical of SCA. However, the cerebrum and brainstem showed no abnormalities (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1).</p>
      </sec>
      <sec id="Sec13">
        <title>Candidate region from linkage analysis</title>
        <p>From the results of linkage analysis, two regions where logarithm of odds (LOD) score was 2 or more were obtained in chromosomes 17 and 21 (Fig.Â <xref rid="Fig1" ref-type="fig">1b</xref>). The maximum LOD scores for chromosomes 17 and 21 were 2.1067 and 2.1066,Â respectively. The candidate region on chromosome 17 was relatively wide, approximately 60Â cM (Fig.Â <xref rid="Fig1" ref-type="fig">1c</xref>). The region did not correspond with any genetic loci of known SCAs.</p>
      </sec>
      <sec id="Sec14">
        <title>Variant filtration</title>
        <p>The results of exome sequencing are shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1. More than 90,000 variants in each sample were called. We narrowed down the candidate variants based on filtering criteria consisting of open databases (dbSNP, 1000 Genomes, and EPS 6400), genomic position, function, and zygosity. A total of 386 variants were common to 1-III-6, 1-III-11, and 1-III-13. Among them, we excluded variants that were observed in other diseases from our in-house variant database, and 11 heterozygous variants remained (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S2).</p>
        <p>Variants that were estimated to be pathogenic by two or more of the three prediction algorithms were as follows: <italic>SLC15A1</italic>, <italic>ALOX15B</italic>, <italic>CACNA1G</italic>, and <italic>RNF213</italic>. We performed segregation of the variants with the disease in the 11 available subjects from family 1. The variants in <italic>ALOX15B</italic> and <italic>CACNA1G</italic> were observed only in affected subjects, but not in unaffected subjects. Based on the linkage analysis, the variant of <italic>CACNA1G</italic> was present in the high LOD region; therefore, we concluded that <italic>CACNA1G</italic> was the most likely candidate. This variant was confirmed by Sanger sequencing (Fig.Â <xref rid="Fig1" ref-type="fig">1d</xref>).</p>
      </sec>
      <sec id="Sec15">
        <title>Heterozygous mutation in <italic>CACNA1G</italic></title>
        <p>Chr17:48694921Gâ&gt;âA corresponded to <italic>CACNA1G</italic>:c.5144Gâ&gt;âA, p.Arg1715His (NM_018896.4, MIM 604065) (Fig.Â <xref rid="Fig1" ref-type="fig">1d</xref>). The <italic>CACNA1G</italic> gene encodes the Ca<sub>V</sub>3.1Â T-type voltage-dependent calcium channel (VDCC). The nucleotide and amino acid sequences of the mutated region were found to be completely conserved among vertebrates (Fig.Â <xref rid="Fig1" ref-type="fig">1f</xref>). The structure of the calcium channel Î± subunit, including Ca<sub>V</sub>3.1, consisted of four repeating domains (repeats IâIV) comprised of five hydrophobic segments (S1â3, S5, and S6) and one positively charged segment (S4) each [<xref ref-type="bibr" rid="CR25">25</xref>]. The identified mutation was located in S4 of repeat IV (Fig.Â <xref rid="Fig1" ref-type="fig">1e</xref>).</p>
        <p>Identical heterozygous mutation was found in the variants obtained by exome sequencing for the sample from 2-III-1 of family 2. No other variants that caused SCA were found in this patient. Sequencing of <italic>CACNA1G</italic> throughout family 2 revealed that affected members harbored the mutation and unaffected members did not. From the results of SNP genotyping performed for linkage analysis, we compared the haplotypes around the <italic>CACNA1G</italic> gene in the two families. Families 1 and 2 shared the haplotypes in the range of 10 and 19Â Mb, respectively. Both families shared the haplotypes for a length of 360Â kb (Fig.Â <xref rid="Fig1" ref-type="fig">1g</xref>).</p>
      </sec>
      <sec id="Sec16">
        <title>Localization of mutant Ca<sub>V</sub>3.1</title>
        <p>Immunocytochemical studies were performed in order to examine the possible changes in the subcellular localization caused by the mutation. We used the NaK-ATPase as a plasma membrane marker. Both wild-type and mutant Ca<sub>V</sub>3.1 were distributed diffusely in the cytoplasm and the plasma membrane (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S2). No significant differences were observed in the localizations of wild-type and mutant Ca<sub>V</sub>3.1.</p>
      </sec>
      <sec id="Sec17">
        <title>Electrophysiological properties</title>
        <p>We examined changes in the electrophysiological properties of mutant Ca<sub>V</sub>3.1. Whole-cell recording was obtained from GFP-positive HEK293T cells expressing wild-type or mutant Ca<sub>V</sub>3.1. To isolate Ca<sup>2+</sup> currents, HEK293T cells were bathed with the extracellular solution containing potassium channel blockers.</p>
        <p>T-type VDCC currents were elicited by depolarizing voltage steps after a hyperpolarizing prepulse to -100Â mV (300Â ms) in HEK293T cells carrying wild-type and mutant constructs (Fig.Â <xref rid="Fig2" ref-type="fig">2a</xref>). The peak current amplitudes are plotted against step voltages in Fig.Â <xref rid="Fig2" ref-type="fig">2b</xref>. In HEK293T cells expressing the mutant construct, amplitudes of T-type VDCC currents were significantly smaller at step voltages of -60 and -70Â mV, but not at higher membrane potential depolarizations (Fig.Â <xref rid="Fig2" ref-type="fig">2a</xref>). This result suggested that the maximum conductance was normal, but that activation of mutant Ca<sub>V</sub>3.1 was shifted to depolarized membrane potentials. To further examine this phenomenon, the, estimated relative conductances were calculated from the peak current-voltage relationships. The reversal potentials used for correction were estimated by line fits of peak amplitudes from -10 to +30Â mV. For each cell, the relative conductance was plotted against depolarizing voltage pulses and fitted by a Boltzmann equation (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>). The averaged half-conductance potential of -57.5âÂ±â9.1Â mV in wild-type (nâ=â9, meanâÂ±âSD) was more hyperpolarized than that of -44.7âÂ±â6.0Â mV in mutant (nâ=â12; <italic>p</italic>â=â0.004, Mann-Whitney <italic>U</italic>-test), suggesting that activation of mutant Ca<sub>V</sub>3.1 was significantly shifted toward more positive membrane potentials. In contrast, the slope factor was not significantly different (wild-type, 6.4âÂ±â2.2Â mV; mutant, 6.2âÂ±â2.9Â mV; <italic>p</italic>â=â0.303), suggesting parallel shift of membrane potential dependent curve to positive potentials. Steady-state inactivation was calculated by fitting the relative amplitudes of the currents as a function of the hyperpolarizing prepulse with the Boltzmann equation (Fig.Â <xref rid="Fig2" ref-type="fig">2d</xref>). Similar to activation, the half-steady-state inactivation potentials were significantly shifted to more positive membrane potentials (wild-type, -79.1âÂ±â6.6Â mV; mutant, -72.5âÂ±â5.5Â mV; <italic>p</italic>â&lt;â0.025), but the slope factor was not significantly different (wild-type, 6.3âÂ±â1.4Â mV; mutant, 7.7âÂ±â1.5Â mV; <italic>p</italic>â=â0.07). As a consequence, the window current shifted toward more positive membrane potentials. The kinetics of the T-type VDCC current were also affected. The inactivation decay time constant of the T-type VDCC currents was significantly slower at small voltage steps in HEK293T cells expressing the mutant construct (Fig.Â <xref rid="Fig2" ref-type="fig">2e</xref>). While it was not statistically significant, a similar trend was also observed for the 10â90Â % rise time (Fig.Â <xref rid="Fig2" ref-type="fig">2f</xref>). These lines of evidence suggested that the mutation affected the voltage dependency of activation and inactivation of the Ca<sub>V</sub>3.1Â T-type VDCCs.<fig id="Fig2"><label>Fig. 2</label><caption><p>Changes in electrophysiological properties. <bold>a</bold> Representative traces of T-type VDCC currents recorded from HEK293T cells expressing wild-type (upper) or mutant (lower) Ca<sub>V</sub>3.1. Holding potential was -60Â mV. Voltage steps were applied after a hyperpolarizing prepulse to -100Â mV (durationâ=â500Â ms). <bold>b</bold> Peak current-voltage plots of VDCC currents of wild-type (blue, <italic>n</italic>â=â9) and mutant (red, <italic>n</italic>â=â12) Ca<sub>V</sub>3.1. <bold>c</bold> Relative conductance-voltage plots. Each data point was calculated from data in B. The black line is a fit using the Boltzmann equation (see Methods). <bold>d</bold> Steady state inactivation-voltage plots. The voltage step to -30Â mV was preceded by incremental hyperpolarizing pulses (durationâ=â300Â ms). Data were obtained from the same cells shown in B and C. The black line is a fit using the Boltzmann equation (see <xref rid="Sec2" ref-type="sec">Methods</xref>). <bold>e</bold> The decay time constants of inactivation of the Ca<sup>2+</sup> current plotted against voltage steps. <bold>f</bold> The 10â90Â % rise times of Ca<sup>2+</sup> currents plotted against voltage steps. Data are presented as the meanâÂ±âSEM. Statistical significance was assessed by Mann-Whitney <italic>U</italic>-test. **<italic>p</italic>â&lt;â0.01, *<italic>p</italic>â&lt;â0.05</p></caption><graphic xlink:href="13041_2015_180_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec18">
        <title>Purkinje cells derived from iPSCs</title>
        <p>We previously reported that the cerebellar neuroepithelium self-organizes in 3D human embryonic stem cell culture. The self-organized cerebellar neuroepithelium differentiates into mature Purkinje cells [<xref ref-type="bibr" rid="CR24">24</xref>]. To examine the ability of the generated iPSCs to differentiate into Purkinje cells, we applied the 3D system to iPSC culture. The differentiated iPSC-derived cells expressed L7. The L7<sup>+</sup> cells developed elaborate dendritic branches and spines that were positive for Purkinje cell-specific glutamate receptor GRID2 (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>, total culture days 51â58). From the result of morphological evaluation of differentiated Purkinje cells, dendritic field areas were 14,367âÂ±â1,026Â Î¼m<sup>2</sup> in control (nâ=â6, meanâÂ±âSD) and 12,287âÂ±â954.8Â Î¼m<sup>2</sup> in patient-derived iPSC (nâ=â6, meanâÂ±âSD; Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3A), and diameters of cell soma were 29.8âÂ±â0.55Â Î¼m in control (nâ=â7, meanâÂ±âSD) and 30.09âÂ±â2.22Â Î¼m in patient-derived (nâ=â7, meanâÂ±âSD; Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3B). There were no obvious differences in the differentiation potentials between control- and patient-derived neurons immunocytochemically and morphologically.<fig id="Fig3"><label>Fig. 3</label><caption><p>iPSC-derived Purkinje cells. Immunostaining of iPSC-derived Purkinje cells on co-culture days 26. GRID2 was expressed in the L7<sup>+</sup> dendritic spines. The scale bars represent 500Â Î¼m (upper panels) and 100Â Î¼m (lower panels)</p></caption><graphic xlink:href="13041_2015_180_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec19">
      <title>Discussion</title>
      <p>Our study revealed that a mutation in <italic>CACNA1G</italic> encoding the T-type calcium channel Ca<sub>V</sub>3.1 causes SCA. This finding is consistent with the fact that several mutations in channel-encoding genes have been reported to cause SCA. We identified the mutation from a large Japanese family with autosomal dominant SCA using exome sequencing and linkage analysis. Moreover, the same mutation was found in another Japanese family with SCA.</p>
      <p>The mutation was located in the S4 segment, which is assumed as a part of the voltage sensor. In particular, the substituted arginine is one of the positively charged residues found every three amino acids; these residues play a central role in voltage sensing. Since simultaneous activation of all four voltage sensors is required to open the calcium channel, the arginine residue mutated in the affected individuals is electrophysiologically important [<xref ref-type="bibr" rid="CR26">26</xref>]. Our electrophysiological analysis supported this concept. While the subcellular distribution and membrane translocation of the protein were normal, membrane potential dependency of activation and inactivation curves of Ca<sup>2+</sup> currents were positively shifted in HEK293T cells expressing mutant Ca<sub>V</sub>3.1. Very recently, identical mutation in <italic>CACNA1G</italic> was reported in French families, which also demonstrated positive shifts in the window current of the T-type channel [<xref ref-type="bibr" rid="CR27">27</xref>]. Alterations of T-type Ca<sup>2+</sup> currents were consistent with our results. The mild physiological changes could explain the clinical features of SCA, including the age at onset and slow progression of the disease.</p>
      <p>Ca<sub>V</sub>3.1 is expressed in the cerebellum, inferior olive nucleus, and the thalamus [<xref ref-type="bibr" rid="CR28">28</xref>]. Physiologically, the channel is associated with high-frequency burst firing of more than 10Â Hz and oscillation [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] and regulates the extension of the axons and dendrites in the developmental stage [<xref ref-type="bibr" rid="CR31">31</xref>]. In animal models, Ca<sub>V</sub>3.1 has been implicated in epilepsy. Ca<sub>V</sub>3.1 knockout mice are unable to elicit thalamocortical low-threshold calcium potentials (LTCPs) and burst firing in response to hyperpolarization and are resistant to drug-induced absence seizures [<xref ref-type="bibr" rid="CR32">32</xref>]. Conversely, overexpression of Ca<sub>V</sub>3.1 in transgenic mice induces thalamocortical spike-wave oscillations characteristic of pure absence epilepsy [<xref ref-type="bibr" rid="CR33">33</xref>]. LTCPs of the thalamus are also important for stabilizing NREM sleep [<xref ref-type="bibr" rid="CR34">34</xref>]. In another study using Ca<sub>V</sub>3.1 knockout mice, Ca<sub>V</sub>3.1 expressed in the inferior olive was shown to be associated with tremor [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
      <p>The clinical picture of our patients was similar to that of SCA6, caused by mutation in another type of calcium channel, <italic>CACNA1A</italic>. Most patients exhibited the pure form of cerebellar ataxia. Notably, two patients had resting tremors. Ca<sub>V</sub>3.1 is expressed at high levels in the cerebellum and inferior olive nucleus. Because T-type VDCCs have important roles in the rhythmogenesis of inferior olivery neurons [<xref ref-type="bibr" rid="CR35">35</xref>], the symptom may also be the consequence of the Ca<sub>V</sub>3.1 mutation. Pyramidal tract signs, which are characteristic of the French families, were not prominent in our cases [<xref ref-type="bibr" rid="CR27">27</xref>]. The fact that the same mutation in the <italic>CACNA1G</italic> gene was independently identified in the different ethnics, Japanese and French further supported the concept of <italic>CACNA1G</italic> as the causative gene for autosomal dominant SCA. Further studies are needed to clarify the clinical characteristics of the <italic>CACNA1G</italic>-dependent SCA in more detail.</p>
      <p>In order to examine the role of <italic>CACNA1G</italic> in neurogenesis, iPSCs derived from the patient were differentiated into Purkinje cells. There were no significant defects in the morphology of Purkinje cells or the expression of Purkinje cell markers, and therefore, the mutation likely did not affect the differentiation of the cells into Purkinje cells. In the future, we are planning on conducting a functional evaluation of induced Purkinje cells.</p>
    </sec>
    <sec id="Sec20">
      <title>Conclusions</title>
      <p>In conclusion, we identified a mutation in <italic>CACNA1G</italic> encoding the T-type calcium channel from two families with dominantly inherited SCA. The mutation is located in the crucial residue of the S4 segment, which functions as a voltage sensor. Our electrophysiological study corroborated these changes in channel properties, and thus, the mutation was likely to be the cause of SCA. We indicated the novel evidence that ion channel dysfunction leads to the pathogenesis of SCA.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec21">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="13041_2015_180_MOESM1_ESM.pptx" id="MOESM1">
              <label>Additional file 1: Figure S1.</label>
              <caption>
                <p>Brain MRI of the patient 2-III-1. The left panel shows the T1-weighted sagittal image, and the right panel shows the T1-weighted axial image. Marked cerebellar vermian atrophy was observed. (PPTX 1622Â kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13041_2015_180_MOESM2_ESM.xlsx" id="MOESM2">
              <label>Additional file 2: Table S1.</label>
              <caption>
                <p>Summary of exome sequencing. (XLSX 42Â kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13041_2015_180_MOESM3_ESM.xlsx" id="MOESM3">
              <label>Additional file 3: Table S2.</label>
              <caption>
                <p>Candidate variants. (XLSX 35Â kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13041_2015_180_MOESM4_ESM.pptx" id="MOESM4">
              <label>Additional file 4: Figure S2.</label>
              <caption>
                <p>Confocal images of HeLa cells expressing wild-type or p.Arg1715His mutant Ca<sub>V</sub>3.1. HeLa cells were transiently transfected with wild-type or p.Arg1715His mutant human Ca<sub>V</sub>3.1 and immunostained with anti- Ca<sub>V</sub>3.1 antibodies (green) and anti-NaK-ATPase antibodies (red) as a membrane marker. Scale bar is 20Â Î¼m. (PPTX 286Â kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13041_2015_180_MOESM5_ESM.pptx" id="MOESM5">
              <label>Additional file 5: Figure S3.</label>
              <caption>
                <p>Morphological measurement of differentiated Purkinje cells. Dendritic field area (A) and diameter of cell soma (B) were measured in differentiated Purkinje cells. Data are presented as the meanâÂ±âSD. Statistical significance was assessed by unpaired <italic>t</italic>-test. (PPTX 274Â kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>SCA</term>
          <def>
            <p>Spinocerebellar ataxia</p>
          </def>
        </def-item>
        <def-item>
          <term>EA</term>
          <def>
            <p>Episodic ataxia</p>
          </def>
        </def-item>
        <def-item>
          <term>gDNA</term>
          <def>
            <p>genomic DNA</p>
          </def>
        </def-item>
        <def-item>
          <term>SNP</term>
          <def>
            <p>Single nucleotide polymorphism</p>
          </def>
        </def-item>
        <def-item>
          <term>PCR</term>
          <def>
            <p>Polymerase chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>iPSC</term>
          <def>
            <p>induced pluripotent stem cell</p>
          </def>
        </def-item>
        <def-item>
          <term>PBMC</term>
          <def>
            <p>Peripheral blood mononuclear cell</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>Magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>LOD</term>
          <def>
            <p>Logarithm of odds</p>
          </def>
        </def-item>
        <def-item>
          <term>VDCC</term>
          <def>
            <p>Voltage-dependent calcium channel</p>
          </def>
        </def-item>
        <def-item>
          <term>LTCP</term>
          <def>
            <p>Low-threshold calcium potential</p>
          </def>
        </def-item>
        <def-item>
          <term>NREM</term>
          <def>
            <p>Non-rapid eye movement</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interest</bold>
        </p>
        <p>The authors report no disclosures relevant to the manuscript.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ contributions</bold>
        </p>
        <p>HK conceived and supervised this project. RM involved in Sanger sequencing. ROh and HMa provided advice on data analysis. TO and ROt involved in data acquisition. MW provided the CACNA1G antibody. HMo, YM, KM, and KH analyzed the data and wrote the paper. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>We thank Ms. Eiko Nakajima, Ms. Masayo Fujiwara, and Ms. Ayaka Nishiyama for their excellent technical assistance. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.K.), a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (H.Mo,. 15Â K15083; H.K., KAKENHI 26242085), and the Core Program for Disease Modeling Using iPS Cells from AMED (K.M.).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durr</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond</article-title>
          <source>Lancet Neurol</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>885</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70183-6</pub-id>
          <?supplied-pmid 20723845?>
          <pub-id pub-id-type="pmid">20723845</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klockgether</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Update on degenerative ataxias</article-title>
          <source>Curr Opin Neurol</source>
          <year>2011</year>
          <volume>24</volume>
          <fpage>339</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1097/WCO.0b013e32834875ba</pub-id>
          <?supplied-pmid 21734495?>
          <pub-id pub-id-type="pmid">21734495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhuchenko</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bonnen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ashizawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stockton</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Amos</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title>
          <source>Nat Genet</source>
          <year>1997</year>
          <volume>15</volume>
          <fpage>62</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0197-62</pub-id>
          <?supplied-pmid 8988170?>
          <pub-id pub-id-type="pmid">8988170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuyama</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kawakami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Komure</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Udaka</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)</article-title>
          <source>Hum Mol Genet</source>
          <year>1997</year>
          <volume>6</volume>
          <fpage>1283</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/6.8.1283</pub-id>
          <?supplied-pmid 9259274?>
          <pub-id pub-id-type="pmid">9259274</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waters</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Minassian</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Stevanin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Figueroa</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Bannister</surname>
              <given-names>JPA</given-names>
            </name>
            <name>
              <surname>Nolte</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes</article-title>
          <source>Nat Genet</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>447</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1758</pub-id>
          <?supplied-pmid 16501573?>
          <pub-id pub-id-type="pmid">16501573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duarri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jezierska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fokkens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schelhaas</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>den Dunnen</surname>
              <given-names>WFA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19</article-title>
          <source>Ann Neurol</source>
          <year>2012</year>
          <volume>72</volume>
          <fpage>870</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.23700</pub-id>
          <?supplied-pmid 23280838?>
          <pub-id pub-id-type="pmid">23280838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>Y-C</given-names>
            </name>
            <name>
              <surname>Durr</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Majczenko</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y-H</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y-C</given-names>
            </name>
            <name>
              <surname>Lien</surname>
              <given-names>C-C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in KCND3 cause spinocerebellar ataxia type 22</article-title>
          <source>Ann Neurol</source>
          <year>2012</year>
          <volume>72</volume>
          <fpage>859</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.23701</pub-id>
          <?supplied-pmid 23280837?>
          <pub-id pub-id-type="pmid">23280837</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jodice</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mantuano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Veneziano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trettel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sabbadini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Calandriello</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p</article-title>
          <source>Hum Mol Genet</source>
          <year>1997</year>
          <volume>6</volume>
          <fpage>1973</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/6.11.1973</pub-id>
          <?supplied-pmid 9302278?>
          <pub-id pub-id-type="pmid">9302278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escayg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Waard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Bichet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia</article-title>
          <source>Am J Hum Genet</source>
          <year>2000</year>
          <volume>66</volume>
          <fpage>1531</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1086/302909</pub-id>
          <?supplied-pmid 10762541?>
          <pub-id pub-id-type="pmid">10762541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The clinical characteristics of spinocerebellar ataxia 36: a study of 2121 Japanese ataxia patients</article-title>
          <source>Mov Disord</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>1158</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.25092</pub-id>
          <?supplied-pmid 22753339?>
          <pub-id pub-id-type="pmid">22753339</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gudbjartsson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Jonasson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Frigge</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Allegro, a new computer program for multipoint linkage analysis</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>12</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1038/75514</pub-id>
          <?supplied-pmid 10802644?>
          <pub-id pub-id-type="pmid">10802644</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ohsawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Newby</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in Twinkle primase-helicase cause Perrault syndrome with neurologic features</article-title>
          <source>Neurology</source>
          <year>2014</year>
          <volume>83</volume>
          <fpage>2054</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000001036</pub-id>
          <?supplied-pmid 25355836?>
          <pub-id pub-id-type="pmid">25355836</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>1754</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
          <?supplied-pmid 19451168?>
          <pub-id pub-id-type="pmid">19451168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Handsaker</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wysoker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fennell</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Homer</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <?supplied-pmid 19505943?>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DePristo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Poplin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Garimella</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hartl</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
          <source>Nat Genet</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>491</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
          <?supplied-pmid 21478889?>
          <pub-id pub-id-type="pmid">21478889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hakonarson</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
          <source>Nucleic Acids Res</source>
          <year>2010</year>
          <volume>38</volume>
          <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
          <?supplied-pmid 20601685?>
          <pub-id pub-id-type="pmid">20601685</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramensky</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sunyaev</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Human non-synonymous SNPs: server and survey</article-title>
          <source>Nucleic Acids Res</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>3894</fpage>
          <lpage>900</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id>
          <?supplied-pmid 12202775?>
          <pub-id pub-id-type="pmid">12202775</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Predicting deleterious amino acid substitutions</article-title>
          <source>Genome Res</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>863</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.176601</pub-id>
          <?supplied-pmid 11337480?>
          <pub-id pub-id-type="pmid">11337480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarz</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>RÃ¶delsperger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schuelke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seelow</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
          <source>Nat Methods</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>575</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>
          <?supplied-pmid 20676075?>
          <pub-id pub-id-type="pmid">20676075</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hildebrand</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Isope</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakaya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Feltz</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional coupling between mGluR1 and Cav3.1Â T-type calcium channels contributes to parallel fiber-induced fast calcium signaling within Purkinje cell dendritic spines</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>9668</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0362-09.2009</pub-id>
          <?supplied-pmid 19657020?>
          <pub-id pub-id-type="pmid">19657020</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morizane</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A more efficient method to generate integration-free human iPS cells</article-title>
          <source>Nat Methods</source>
          <year>2011</year>
          <volume>8</volume>
          <fpage>409</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.1591</pub-id>
          <?supplied-pmid 21460823?>
          <pub-id pub-id-type="pmid">21460823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Amano</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells</article-title>
          <source>Stem Cells</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>458</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1002/stem.1293</pub-id>
          <?supplied-pmid 23193063?>
          <pub-id pub-id-type="pmid">23193063</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muguruma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miyawaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mizuhara</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells</article-title>
          <source>Nat Neurosci</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>1171</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1038/nn.2638</pub-id>
          <?supplied-pmid 20835252?>
          <pub-id pub-id-type="pmid">20835252</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muguruma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawakami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sasai</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Self-Organization of Polarized Cerebellar Tissue in 3D Culture of Human Pluripotent Stem Cells</article-title>
          <source>Cell Rep</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>537</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.051</pub-id>
          <?supplied-pmid 25640179?>
          <pub-id pub-id-type="pmid">25640179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>McCue</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Velicelebi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>SB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype</article-title>
          <source>Neuron</source>
          <year>1992</year>
          <volume>8</volume>
          <fpage>71</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/0896-6273(92)90109-Q</pub-id>
          <?supplied-pmid 1309651?>
          <pub-id pub-id-type="pmid">1309651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sigworth</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Structural biology: Lifeâs transistors</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>423</volume>
          <fpage>21</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1038/423021a</pub-id>
          <?supplied-pmid 12721605?>
          <pub-id pub-id-type="pmid">12721605</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="other">Coutelier M, Blesneac I, Monteil A, Monin M-L, Ando K, Mundwiller E, Brusco A, Le Ber I, Anheim M, Castrioto A, Duyckaerts C, Brice A, Durr A, Lory P, Stevanin G. A Recurrent Mutation in CACNA1G Alters Cav3.1Â T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. Am J Hum Genet 2015;97:1â12.</mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talley</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Cribbs</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Daud</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Perez-Reyes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bayliss</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels</article-title>
          <source>J Neurosci</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>1895</fpage>
          <lpage>911</lpage>
          <?supplied-pmid 10066243?>
          <pub-id pub-id-type="pmid">10066243</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tscherter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ivanova</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Deleuze</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Renger</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Uebele</surname>
              <given-names>VN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Minimal alterations in T-type calcium channel gating markedly modify physiological firing dynamics</article-title>
          <source>J Physiol</source>
          <year>2011</year>
          <volume>589</volume>
          <issue>Pt 7</issue>
          <fpage>1707</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2010.203836</pub-id>
          <?supplied-pmid 21320888?>
          <pub-id pub-id-type="pmid">21320888</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>Y-G</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H-Y</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>10731</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1002995107</pub-id>
          <?supplied-pmid 20498062?>
          <pub-id pub-id-type="pmid">20498062</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lory</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bidaud</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Chemin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>T-type calcium channels in differentiation and proliferation</article-title>
          <source>Cell Calcium</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>135</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceca.2006.04.017</pub-id>
          <?supplied-pmid 16797068?>
          <pub-id pub-id-type="pmid">16797068</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Keum</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels</article-title>
          <source>Neuron</source>
          <year>2001</year>
          <volume>31</volume>
          <fpage>35</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00343-9</pub-id>
          <?supplied-pmid 11498049?>
          <pub-id pub-id-type="pmid">11498049</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ernst</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Noebels</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Genetic enhancement of thalamocortical network activity by elevating alpha 1Â g-mediated low-voltage-activated calcium current induces pure absence epilepsy</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>1615</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2081-08.2009</pub-id>
          <?supplied-pmid 19211869?>
          <pub-id pub-id-type="pmid">19211869</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>H-S</given-names>
            </name>
          </person-group>
          <article-title>Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>18195</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0408089101</pub-id>
          <?supplied-pmid 15601764?>
          <pub-id pub-id-type="pmid">15601764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lampl</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yarom</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Subthreshold oscillations and resonant behavior: two manifestations of the same mechanism</article-title>
          <source>Neuroscience</source>
          <year>1997</year>
          <volume>78</volume>
          <fpage>325</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(96)00588-X</pub-id>
          <?supplied-pmid 9145790?>
          <pub-id pub-id-type="pmid">9145790</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>